WST Stock News 41.93 05/15/2014 16:06:49 West Pharmaceutical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
West Pharmaceutical Services (WST) 41.93 $WST

West to Host Analyst and Investor Day
Marketwire - Wed May 14, 7:30AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company will host an Analyst and Investor Day for financial analysts on Thursday, May 22, 2014 from 8:30 am to 11:30 am EDT in New York, NY. Members of West's senior management will provide an overview of the company's current markets, operations, and growth opportunities. Presentations will begin at 9:00 am EDT.

West Announces Third Quarter 2014 Dividend
Marketwire - Thu May 08, 6:30AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved payment of the third-quarter 2014 cash dividend of $0.10 per share. The dividend will be paid on August 6, 2014 to shareholders of record on July 23, 2014.

West to Present at Upcoming Investor Conferences
Marketwire - Wed May 07, 5:20AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in three upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences:

'Mad Money' Lightning Round: Valero Is Amazing
at The Street - Tue May 06, 5:00AM CDT
Cramer does not like Plug Power but he wants Old Republic International.

Jim Cramer's 'Mad Money' Recap: Market Headwinds Getting Worse
at The Street - Mon May 05, 6:59PM CDT
Investors are just as likely to lose money as they are to make money on any given day, and there are a host of good reasons why, Cramer says.

West Announces First Quarter 2014 Results
Marketwire - Thu May 01, 6:03AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2014 and updated its financial guidance for the year.

West to Host First Quarter 2014 Conference Call
Marketwire - Thu Apr 24, 7:31AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter 2014 financial results before the market opens on Thursday, May 1, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-383-8009 (U.S.) or 617-597-5342 (International). The passcode is 97017517.

First Week of May 17th Options Trading For West Pharmaceutical Services (WST)
DividendChannel.com - Mon Apr 21, 10:06AM CDT
Investors in West Pharmaceutical Services, Inc. saw new options become available this week, for the May 17th expiration.

Dividend Watch: 2 Stocks Going Ex-Dividend Monday: WST, CLX
at The Street - Thu Apr 17, 9:00AM CDT
WST CLX are going ex-dividend Monday, Monday, April 21, 2014, 4:00 AM ET

Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018
M2 - Wed Apr 16, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3qkddr/pharmaceutical) has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type. Raw Material & Drug Delivery Type - Global Trends & Forecast to 2018" report to their offering. The global pharmaceutical packaging market by product type and drug delivery type, has witnessed a significant growth in the past few years and this growth is estimated to persist in the coming years. The primary pharmaceutical packaging products constitute majority of the market globally. While plastic bottles, blister packs, caps & closures, labels & accessories contribute largely to the pharmaceutical packaging market; pre-fillable syringes, inhalers, medication tubes, and other new products will drive the future growth in the industry. North America, Western Europe and Japan dominated the pharmaceutical packaging market in 2012 and accounted for over 70% of the market. These developed regions dominate the packaging market due their mature markets which consist of health conscious and high-spending population. On the other hand, Asia-Pacific is expected to overtake the North American & European pharmaceutical packaging markets on account of its fastest-double digit growth rate by 2018. The market in this region is spurred by the large economies of Japan, China, and India that are experiencing increased contract manufacturing activities, growth of pharmaceutical sector, increased government investment in healthcare facilities, and ageing population. The global pharmaceutical packaging market is expected to grow at a CAGR of 6.7% from 2013 to 2018 to reach a value of $78.79 billion. The packaging market by drug delivery type is growing at a CAGR of 9.1% and constitutes a significant part of the overall pharmaceutical packaging market. The market is expected to be pushed by off-patenting of drugs, expanding generics market, and rapidly growing drug delivery market. Due to increasing generic and contract manufacturing activities in Asia-Pacific, especially in India and China, the emerging geographies are expected to register maximum growth. Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insight - Market Dynamics - Pharmaceutical Packaging Market, By Packaging Type - Pharmaceutical Packaging Market, By Packaging Material - Pharmaceutical Packaging Market, By Drug Delivery Type - Pharmaceutical Packaging Market, By Geography - Packaging Market For Veterinary Vaccines - Competitive Landscape - Company Profiles - Amcor Ltd. - Aptargroup, Inc. - Becton, Dickinson & Company - Capsugel Inc. - Catalent Pharma Solutions Inc. - Ccl Industries Inc. - Clondalkin Group Holdings B.V. - Datwyler Holding Inc. - Gerresheimer Ag - Global Closure Systems Ltd - Intrapac Group - Klockner Pentaplast Group - Meadwestvaco Corporation - Nypro Inc. - Rexam Plc - Rpc Group Plc - Schott Ag - Steripack Limited - Vitro, S.A.B. De C.V. - West Pharmaceutical Services, Inc. - Wihuri Group For more information visit http://www.researchandmarkets.com/research/3q...maceutical

Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled

West Pharmaceutical Services, Inc. Uses Esker Cloud Fax Services to Simplify and Streamline Faxing
Business Wire - Tue Apr 15, 7:01AM CDT
Esker, a worldwide leader in document process automation solutions and SAP(R) software solution and technology partner, announced today that West Pharmaceutical Services, Inc. (West), a designer and manufacturer of pharmaceutical packaging and delivery systems, is leveraging Esker Cloud Fax Services to automate its inbound and outbound faxing. The initiative allows West to increase the speed, accuracy and reliability of its faxing operations while achieving full reporting capabilities within the SAP interface.

Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Bristol-Myers Squibb Company (NYSE: BMY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Illumina Inc. (NASDAQ: ILMN), and West Pharmaceutical Services, Inc. (NYSE: WST). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

West to Present at Barclays Conference
Marketwire - Thu Mar 06, 7:02AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the 2014 Barclays Global Healthcare Conference Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Thursday, March 13, 2013 at 9:00 AM Eastern Time.

Concise Analysis of the International Bolus Injectors Market, 2014 - 2024
M2 - Tue Mar 04, 6:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/jpbd3g/bolus_injectors) has announced the addition of the "Concise Analysis of the International Bolus Injectors Market, 2014 - 2024" report to their offering. The injectable drug delivery market holds significant potential for the future. From conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and auto-injectors, the injectable drug delivery devices market has come a long way. Taking the concept of self-injectors to a new stratum, Bolus Injectors' have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry. One of the main drivers for the perceived growth of bolus injectors is the large number of biologics currently under development. A majority of these molecules are highly viscous and are required to be delivered in volumes of greater than 1 ml. The absence of devices which can safely administer these drugs is currently a big unmet need in the market. However, the early signs are encouraging. Despite the uncertainties related to the device development and approval, many companies are investing time, money and resources to develop novel devices. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Overview And Market Background 4. Target Drugs For Bolus Injectors 5. Product Profiles 6. Market Size And Forecast 7. Swot Analysis 8. Company Profiles 9. Interview Transcripts 10. Conclusion 11. Appendix 1: Tables 12. Appendix 2: List Of Companies Companies Mentioned: - AbbVie - Abbott - BMS - Boehringer Ingelheim - Calando Pharmaceuticals - Calibra Medical - Dekkun - Denderon - Eisai - Elcam Medical - Eli Lilly - Five Prime Therapeutics - Future Injection Technologies - Genentech - Genethon - Isis Pharmaceuticals - J&J - Janssen Biotech - Kyowa Hakko Kirin - Lincoln Medical Limited - MacroGenics - Nuron Biotech - Octapharma - OncoGenex Technologies - Pfizer - PhaseBio Pharmaceuticals - Roche - SteadyMed Therapeutics - Synageva BioPharma - TaiMed Biologics - Takeda Pharmaceuticals - VBL Therapeutics - West Pharmaceutical Services - Xbiotech - Ypsomed - ZZ Biotech For more information visit http://www.researchandmarkets.com/research/jp..._injectors

Insider Trading Alert - KMB, IBKR And WST Traded By Insiders
at The Street - Thu Feb 27, 9:30AM CST
Stocks with insider trader activity include KMB, IBKR and WST

Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.

West Pharm sales fall short
at Investor's Business Daily - Thu Feb 20, 6:14PM CST
The maker of packaging and delivery devices for drugs and related consumer products said Q4 EPS climbed 22.6% to 38 cents, in line with estimates. Revenue rose 7.8% to $346.6 mil, below projections for $348.7 mil. West Pharmaceutical (WST) forecast...

West Appoints Director and Announces Second Quarter 2014 Dividend
Marketwire - Thu Feb 20, 7:22AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to eleven and appointed Myla Lai-Goldman, M.D., for a term that will expire at the 2014 Annual Meeting of Shareholders, when she will stand for election.

West Announces Fourth Quarter 2013 Results
Marketwire - Thu Feb 20, 6:01AM CST
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2013 and provided annual financial guidance for 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 68

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 90

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 78

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 8

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 12

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 133

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Hoymiles Brings Plug-In Solar Flexibility to RE+ 2026

Updated Category News Views 70

A 1.8-kilogram box may not sound like much, but it captures where household solar is trying to go: smaller, less intimidating, and far easier to put to work. At RE+ 2026 in Las Vegas, Hoymiles laid out a residential lineup spanning plug-in solar, battery storage and conventional rooftop microinverters. This was not one flashy gadget looking for applause. It was a fairly...

Continue Reading

Top 5 Most Recently Viewed Articles

Donnette Irving Takes Charge of Navis Pack & Ship Atlanta

Updated Category News Views 179

Donnette Irving Takes Charge of Navis Pack & Ship Atlanta Annex Brands, Inc. is expanding its presence in the oversized freight shipping and crating sector through recent developments at the Navis Pack & Ship location in Atlanta. The transition of ownership marks an exciting new chapter for the established franchise, now led by Donnette Irving, who is determined to uphold...

Continue Reading
Impact of EU’s Urban Wastewater Directive on Finland’s Pharmaceutical Industry

Updated Category News Views 175

Understanding the EU’s Urban Wastewater Treatment Directive The newly enforced Urban Wastewater Treatment Directive by the EU, effective from January 1, 2025, carries significant implications for various industries, particularly pharmaceuticals. This directive requires manufacturers in the pharmaceutical, cosmetics, and hygiene sectors to take charge of the costs...

Continue Reading
Innovations in OpenTelemetry Transform Digital Resilience for Businesses

Updated Category News Views 200

Enhancing Observability with OpenTelemetry Innovations New observability innovations empower organizations to apply OpenTelemetry to large-scale environments with complete business visibility Splunk, the cybersecurity and observability leader, has unveiled groundbreaking innovations designed to improve the OpenTelemetry experience. These advancements equip organizations...

Continue Reading
Abeona Therapeutics Expands Workforce with New Stock Grants

Updated Category News Views 158

Abeona Therapeutics Enhances Employee Inducement Programs Abeona Therapeutics Inc. has recently made significant strides in its workforce development by offering new equity awards to non-executive employees who joined the company. This move aligns with the company's commitment to fostering a dynamic work environment and was sanctioned under Nasdaq Listing Rule 5635(c)(4)....

Continue Reading
MIND Technology, Inc. Achieves Impressive Fiscal Growth

Updated Category News Views 190

MIND Technology, Inc. Reports Strong Fiscal Growth in Fourth Quarter MIND Technology, Inc. (NASDAQ: MIND), a leading provider of technology solutions for marine industries, recently revealed its financial performance for the fourth quarter and year-end results. The company reported noteworthy revenues, highlighting impressive growth compared to previous quarters. Revenue...

Continue Reading